ABSTRACT. We investigated the hypothesis that purine nucleotides, ATP and adenosine, mediate the pulmonary vasodilation that occurs at birth in response to an increase in arterial O2 pressure (Pao2). We studied 20 fetal lambs 1 to 3 d after placement of intravascular catheters and a flow transducer around left pulmonary artery. In 16 lambs, we investigated the effects of I) an increase in fetal Pao2 on ATP levels in pulmonary circulation and 2) &phenyl-theophylline (8-PT) and cibacron blue, antagonists of receptors for adenosine and ATP, on pulmonary vasodilation caused by increased Pao2. In four other lambs, we investigated the specificity of 8-PT and cibacron blue for purine receptors by investigating their effects on pulmonary vasodilation caused by acetylcholine, bradykinin, and nitroprusside. The fetal Pao2 increased by 7 +: 2 during administration of 100% O2 to the pregnant ewe, resulting in a 3-fold decrease in PVR and increase in pulmonary blood flow. Blood and plasma concentrations of ATP in fetal pulmonary artery and left atrium increased significantly during the increase in fetal Pao2. 8-PT and cibacron blue caused increases in baseline pulmonary and systemic vascular pressures and pulmonary vascular resistance and inhibited the pulmonary vasodilation caused by 0 2 . 8-PT and cibacron blue did not alter the pulmonary vascular effects of acetylcholine, bradykinin, and nitroprusside. An increase in baseline pulmonary vascular resistance caused by infusion of U46619 (in four lambs) did not alter the pulmonary vasodilation caused by 0 2 . In summary, 0 2 -induced pulmonary vasodilation is accompanied by increased ATP levels in pulmonary circulation and is attenuated by antagonists of purine receptors. Adenosine and ATP are important mediators of 02-induced pulmonary vasodilation in fetal lambs. (Pediatr Res 33: 533-539, 1993) Abbreviations PVR, pulmonary vascular resistance 8-PT, 8-phenyltheophylline ANOVA, analysis of variance Pao2, arterial O2 pressure Paco2, arterial C 0 2 pressure EDNO, endothelium-derived nitric oxide Hb O2 Sat, hemoglobin O2 saturation RBC, red blood cell PVR in the fetus undergoes a dramatic decrease at birth, accompanied by a 10-fold increase in pulmonary blood flow (I). The factors that decrease PVR at birth include onset of ventilation (2) and exposure to higher O2 tension (3-6). Previous studies done in fetal lambs have shown that distension of lung alone causes a small decrease in PVR and that this response is modulated by prostaglandins (7, 8). Increase in O2 tension in the fetus to postnatal levels, however, causes the 10-fold increase in pulmonary blood flow and decrease in PVR that occur at birth (6). The effect of O2 on PVR appears to be independent of prostaglandin synthesis (8, 9). Recent studies (10) have shown that vascular endothelium regulates the decrease in PVR at birth in fetal lambs by synthesis of EDNO. However, the factors that stimulate the synthesis of EDNO at birth are not known.
ABSTRACT. We investigated the hypothesis that purine nucleotides, ATP and adenosine, mediate the pulmonary vasodilation that occurs at birth in response to an increase in arterial O2 pressure (Pao2). We studied 20 fetal lambs 1 to 3 d after placement of intravascular catheters and a flow transducer around left pulmonary artery. In 16 lambs, we investigated the effects of I) an increase in fetal Pao2 on ATP levels in pulmonary circulation and 2) &phenyl-theophylline (8-PT) and cibacron blue, antagonists of receptors for adenosine and ATP, on pulmonary vasodilation caused by increased Pao2. In four other lambs, we investigated the specificity of 8-PT and cibacron blue for purine receptors by investigating their effects on pulmonary vasodilation caused by acetylcholine, bradykinin, and nitroprusside. The fetal Pao2 increased by 7 +: 2 during administration of 100% O2 to the pregnant ewe, resulting in a 3-fold decrease in PVR and increase in pulmonary blood flow. Blood and plasma concentrations of ATP in fetal pulmonary artery and left atrium increased significantly during the increase in fetal Pao2. 8-PT and cibacron blue caused increases in baseline pulmonary and systemic vascular pressures and pulmonary vascular resistance and inhibited the pulmonary vasodilation caused by 0 2 . 8-PT and cibacron blue did not alter the pulmonary vascular effects of acetylcholine, bradykinin, and nitroprusside. An increase in baseline pulmonary vascular resistance caused by infusion of U46619 (in four lambs) did not alter the pulmonary vasodilation caused by 0 2 . In summary, 0 2 -induced pulmonary vasodilation is accompanied by increased ATP levels in pulmonary circulation and is attenuated by antagonists of purine receptors. Adenosine and ATP are important mediators of 02-induced pulmonary vasodilation in fetal lambs. (Pediatr Res 33: 533-539, 1993) Abbreviations PVR, pulmonary vascular resistance 8-PT, 8-phenyltheophylline ANOVA, analysis of variance Pao2, arterial O2 pressure Paco2, arterial C 0 2 pressure EDNO, endothelium-derived nitric oxide Hb O2 Sat, hemoglobin O2 saturation RBC, red blood cell PVR in the fetus undergoes a dramatic decrease at birth, accompanied by a 10-fold increase in pulmonary blood flow (I). The factors that decrease PVR at birth include onset of ventilation (2) and exposure to higher O2 tension (3) (4) (5) (6) . Previous studies done in fetal lambs have shown that distension of lung alone causes a small decrease in PVR and that this response is modulated by prostaglandins (7, 8) . Increase in O2 tension in the fetus to postnatal levels, however, causes the 10-fold increase in pulmonary blood flow and decrease in PVR that occur at birth (6). The effect of O2 on PVR appears to be independent of prostaglandin synthesis (8, 9). Recent studies (10) have shown that vascular endothelium regulates the decrease in PVR at birth in fetal lambs by synthesis of EDNO. However, the factors that stimulate the synthesis of EDNO at birth are not known.
We previously reported that adenosine and ATP are pulmonary vasodilators in fetal (1 1) and postnatal lambs (12, 13) and that they dilate the pulmonary vessels by stimulation of PI and P2 purinergic receptors. We also reported (1 1) that the blood ATP and adenosine levels in fetal pulmonary circulation are lower than in postnatal lambs. ATP and adenosine have been shown to stimulate EDNO release in pulmonary vessels of newborn (14) and fetal lambs (15). We therefore proposed the hypothesis that increased synthesis and release of ATP by the vascular endothelial cells and/or red cells into plasma, in response to an increase in Pao2 at birth, causes pulmonary vasodilation in fetal lambs. The ATP released by the cells is rapidly converted by ectoenzymes to adenosine (16), which causes pulmonary vasodilation by stimulation of a different (PI) receptor from ATP. The pulmonary vascular effects of adenosine are blocked by 8-PT, a P, receptor antagonist, and the effects of ATP are blocked by cibacron blue, a P2 receptor antagonist (1 I). However, it is not known whether these purine antagonists have nonspecific effects on other vasodilator mechanisms in pulmonary circulation. It is also not clear whether the effect of purine antagonists on baseline vascular tone have an independent influence on pulmonary vasodilator response to 02.
Previous studies (17, 18) Surgical preparation. The ewe underwent a sterile surgical procedure under general anesthesia with isoflurane and O2 administered via an endotracheal tube. The fetus was exposed by a midline laparotomy incision and an incision in the uterus close to the fetal head. Catheters made from Tygon tubing (Baxter Diagnostics Inc., McGaw Park, IL) were inserted into the ascending aorta and right atrium via the carotid artery and jugular vein. A left lateral thoracotomy was then done on the fetus to insert catheters into the left pulmonary artery and left atrium and an ultrasonic flow transducer (size 6 S, Transonic Systems Inc., Ithaca, NY) around the left pulmonary artery. A large-bore catheter was placed in the amniotic cavity to replace amniotic fluid with lactated Ringer's solution and to measure the amniotic cavity pressure, which served as zero reference for fetal intravascular pressures. The catheters and cable for flow transducer were exteriorized to the flank of the ewe. The fetus was returned to the uterine cavity, and uterine and abdominal incisions were closed. Antibiotics (procaine penicillin, 2 million U, and gentamicin, 250 mg intramuscularly) were administered to the ewe on the day of surgery and on each postoperative day.
Study protocol. Each animal was allowed to recover for I to 3 d before experiments were done. For a study, the ewe was placed in a cage in the study area and was allowed free access to alfalfa pellets and water. The fetal intravascular catheters and amniotic fluid catheter were connected to strain-gauge manometers (P23 XL, Spectramed Electronics Inc., Critical Care Division, Oxnard, CA), and the flow transducer was connected to an ultrasonic transit-time blood flow meter (Transonic Systems Inc.). Zero flow output from the flowmeter was used as baseline, and mean flow output above baseline was used as the mean pulmonary blood flow. Aortic, pulmonary arterial, left and right atrial pressures, and pulmonary blood flow were recorded on a Grass model 7D polygraph (Grass Instruments, Quincy, MA). The fetal PVR was calculated as the difference between left pulmonary arterial and left atrial pressures divided by left pulmonary flow, measured as mL/min.
Drugpreparation. Acetylcholine hydrochloride and bradykinin were obtained from Sigma Chemical Co. (St. Louis, MO) in a powder form, and the solution for i.v. administration was prepared each day by mixing it with sterile 0.9% saline to give a final concentration of 100 pg/mL and 10 pg/mL, respectively. Sodium nitroprusside was mixed with 5% dextrose water to give a final concentration of 10 pg/mL. 8-PT was obtained from Sigma in a powder form, and the total dose of 20 mg (7 mg/kg for the average weight of fetus) was dissolved in 3 mL of ethyl alcohol. Cibacron blue (Sigma) was dissolved in normal saline to provide the total dose of 15 mg (5 mg/kg) in 3 mL of solution. We previously reported (1 1) that these doses of purine antagonists cause attenuation of pulmonary vasodilation caused by adenosine and ATP infusions at doses of 0.08 to 2.5 pmol/kg/min. One mg of U46619 (Sigma) was dissolved in 1 mL of ethyl alcohol, and 100 pg were subsequently dissolved in 50 mL of sterile water for infusion.
Protocol 1: investigation of specificity of purine antagonists. Four fetal lambs were studied three times each on separate days. Control experiments were done with infusion of acetylcholine in doses of 25, 50, and 100 pg/min into the right atrial line with a Harvard infusion pump (Harvard Apparatus, Co., Inc., So. Natick, MA). Each infusion rate was maintained for 10 min, and variables were measured at the end of a 10-min infusion. The animal was allowed to recover for 10 min between doses and for 1 to 2 h after the last dose. Hemodynamic variables recovered to baseline by the end of 1 h. Bradykinin was then infused into the right atrial line in doses of 2, 5, and 10 pg/min at 10-min intervals, followed by recovery for 1 to 2 h. Finally, nitroprusside was infused into the left pulmonary artery at doses of 2, 5, and 10 pg/min at 10-min intervals. Hemodynamic variables were recorded at the end of a 10-min infusion of each dose of bradykinin and nitroprusside. The experiments lasted 6 h each day, and the pregnant ewes tolerated the studies well without agitation. On a separate day, the animals were given 20 mg of 8-PT into the left pulmonary artery, and variables were recorded after 20 min. The infusion of three vasodilators was then repeated in sequence, as described for control experiments. On a different day, the fetal lamb was given cibacron blue into the left pulmonary artery in a dose of 15 mg, and the infusion of three vasodilators was repeated. The doses of vasodilators were chosen based on pilot studies showing a range of 2-to 5-fold increase in pulmonary blood flow at these doses. The doses of 8-PT and cibacron blue chosen have been shown previously to cause attenuation of pulmonary vascular effects of adenosine and ATP, respectively (1 1). We used the same doses of blockers in our experiments with 0 2 , as described below. We allowed the animals to recover for 24 h between studies with the PI and P2 receptor blockers and randomized the order in which the studies were performed. The duration of the blockade caused by these drugs has not been investigated in fetal lambs, but the baseline hemodynamic variables before each study were comparable.
Protocol 2: effects of O2 on fetal pulmonary circulation before and after purine receptor blockade. Sixteen fetal lambs were studied twice each on separate days. For control experiments, baseline hemodynamic variables were recorded when the ewe was breathing room air. Blood samples were obtained from fetal pulmonary artery and left atrium to measure the blood and plasma concentrations of ATP and from fetal aorta to measure the arterial blood gas tensions and blood pH. Blood samples for ATP determinations were drawn only during control experiments. The fetal Pa02 was then increased by exposing the pregnant sheep to 100% 0 2 given via a plastic bag placed over the ewe's head at 20 to 30 L/min. The ewes were conditioned by having them breathe through the plastic bag on at least two occasions before the actual experiment. They tolerated the experiment well and did not show agitation. Accurso et al. (5) have reported a 5-mm Hg (0.7 kPa) increase in fetal Pao2 and a 3-fold increase in pulmonary flow by administration of 100% O2 to the pregnant sheep. The maximal changes were reported to occur at 40 min after beginning of exposure to O2 in their studies, done at an altitude of 1500 M. However, we found that maximal response to O2 occurs at 20 min with an average increase in Pao, of 7 mm Hg (0.9 kPa) in our studies done at sea level. Hemodynamic variables were recorded, and blood samples were obtained for ATP levels and arterial blood gas tensions and pH at ATP AND OXYGEN-INDI JCED DECREASE IN PVR 535 10 and 20 min after the beginning of exposure to 0 2 . The ewe was then returned to room air and to the cage. After a 24-h interval, the second experiment was done on the same animal. Baseline variables were recorded, and the fetal lamb was given 20 mg of 8-PT into the left pulmonary artery, followed after 10 min by 15 mg of cibacron blue. These drugs were given to block both PI and P2 purinergic receptors, respectively. Variables were recorded 20 min after administration of cibacron blue. The exposure of the ewe to 100% O2 was then repeated as described for control experiments. Hemodynamic variables and arterial blood gases were checked 10 and 20 rnin after the beginning of exposure to 0 2 . The volume of each blood sample was 0.5 mL each for blood and plasma ATP levels from pulmonary artery and left atrium and 0.3 mL for blood gas determination. The total volume of blood taken was 7 mL for each control study and 1 mL for studies done after the administration of purine blockers. The total volume of 8 mL represents 3% of blood volume (assuming 85 mL/kg and average fetal weight of 2.9 kg) taken over 2 d and did not affect the baseline hemodynamic variables.
Protocol 3: effect of U46619 infusion on 02-induced pulmonary vasodilation. Four of the 16 fetal lambs were given an infusion of U46619 into the left pulmonary artery in a dose of 0.75 pg/ min. Baseline variables were recorded 10 min after the beginning of infusion. The dose of U46619 was found to increase the pulmonary artery pressure and PVR to the same extent as 8-PT and cibacron blue. Exposure of the pregnant ewe to 100% 0 2 was repeated as described above. Experiments with U466 19 were done on a separate day, and the order of control, purine blocker, and U46619 experiments was randomized for each animal.
Assay for ATP. Blood samples for ATP levels were collected rapidly into heparinized syringes and were placed immediately into tubes with trichloroacetic acid kept at 0 to 4°C and into EDTA tubes. The samples were immediately centrifuged, and supernatant was separated and kept frozen at -20°C. Samples treated with trichloroacetic acid underwent immediate lysis of red cells, and the ATP levels in these samples represented the combined amount in red cells and plasma. Samples treated with EDTA allowed us to measure the levels in plasma alone. Assay for ATP was done using the firefly luciferin-luciferase bioluminescence method (19) . ATP is consumed and light is emitted when firefly luciferase catalyzes the oxidation of P-luciferin. The amount of light emitted during the reaction is proportional to availability of ATP. Samples were diluted 1000-fold with a 10-mM phosphate buffer and were run in triplicate against a 10-point standard curve. Internal standardization for each sample was also done in triplicate using a I-pM solution of ATP (10 pL/ 100 pL of sample). Luminescence was measured using a Berthold Luminometer (Lumat LB 950 1, EG&G Berthold Analytical Instruments Inc., Nashua, NH). Blood and plasma ATP levels were expressed as pmol/L. The intraassay coefficient of variation was 1.3 to 2.696, and the interassay coefficient of variation was 7%. The smallest detectable concentration of ATP using this method was 1 pmol/L. Statistical analysis. Data are expressed as means + 1 SD.
Baseline data obtained on different days for each experiment were compared by single-factor ANOVA for repeated measures to determine if baseline variables were similar on each day. Data obtained with each vasodilator in the control experiments were compared with those obtained after PI and P2 blockers by twoway ANOVA for repeated measures (20) . The control data obtained during exposure to O2 were compared with data obtained with purine blockers by two-way ANOVA for repeated measures. Blood ATP levels obtained during exposure to 0 2 were compared with baseline by single-factor ANOVA. When significant differences (p < 0.05) were found, a Duncan's multiplerange test was done to determine which means were different.
RESULTS
The fetal lambs were of normal weight (2.9 + 0.4 kg) and had normal blood pH (7.39 + 0.03) and Po2 (18 + 3 torr or 2.5 + 0.5 kPa) at the time of study. Baseline variables measured on different days were comparable and showed no significant differences. Acetylcholine and bradykinin (Fig. 1 ) caused significant decreases in PVR and increases in pulmonary blood flow at all doses tested in the control experiments. 8-PT and cibacron blue increased the PVR from control. They did not alter the pulmonary vascular effects of acetylcholine and bradykinin. Nitroprusside (Fig. 2) caused a significant decrease in PVR and increase in pulmonary flow at 5-and 10-pg/min infusion rates. 8-PT and cibacron blue attenuated the increase in pulmonary flow at 5-pg/min infusion rate of nitroprusside. However, the purine blockers did not alter the decrease in PVR caused by nitroprusside.
Exposure of the pregnant ewe to 100% 0, resulted in significant increases in Pao2, Paco2, and Hb O2 Sat ( Table 1 ). The increases in fetal Pao2 and Hb O2 Sat with O2 in lambs pretreated with purine antagonists were comparable to those in control experiments. The blood pH showed a small but statistically significant decrease after the administration of purine blockers ( Table 1) . The blood ATP levels in the pulmonary artery increased at 20 min and in the left atrium at 10 and 20 min after beginning exposure to O2 in control experiments ( Table 2 ). The plasma ATP levels in the pulmonary artery and left atrium increased at 10 and 20 rnin after the increase in fetal Pao2 ( Table  2 ). The increase in ATP levels coincided with the increase in pulmonary blood flow and the decrease in PVR (Table 3) .
The increase in Pao2 in control experiments was associated with a significant increase in left pulmonary blood flow and a decrease in PVR at 10 and 20 min after beginning exposure to O2 (Table 3) . 8-PT and cibacron blue caused significant increases in baseline systemic and pulmonary arterial pressures and PVR (Table 3) . Pretreatment of fetal lambs with purine antagonists prevented the decrease in PVR and increase in pulmonary blood flow during the increase in Pao2. Infusion of U46619 caused significant increases in baseline pulmonary and systemic vascular pressures and PVR. However, U466 19 infusion did not attenuate the pulmonary vasodilation caused by 0 2 . DISCUSSION We provide evidence to support our hypothesis that ATP and its metabolite, adenosine, mediate 02-induced pulmonary vasodilation in fetal lambs. The blood and plasma ATP levels in fetal pulmonary circulation increased during an increase in fetal Pao,. Inhibition of receptors for adenosine and ATP caused attenuation of the 02-induced pulmonary vasodilation. We also provide evidence that the purine receptor antagonists used in this study do not alter the response of pulmonary circulation to other endothelium-dependent and -independent vasodilators. The inhibition of 02-induced pulmonary vasodilation caused by these drugs is independent of their effects on baseline pulmonary vascular tone. These studies show that 8-PT and cibacron blue cause attenuation of 02-induced pulmonary vasodilation by a specific effect on purine receptors in pulmonary circulation.
O2 appears to be the major stimulus that decreases PVR at birth. Morin et al. (6) have shown that an increase in fetal Pao2 to postnatal levels, without distension of lungs, increases the pulmonary blood flow to levels seen in newborn lambs. The effect of O2 on fetal pulmonary circulation is independent of prostaglandin synthesis (9). Our previous studies (1 1) indicated that adenosine and ATP are pulmonary vasodilators capable of increasing the pulmonary blood flow to postnatal levels in fetal sheep. The pulmonary vasodilation caused by ATP is also independent of prostaglandin synthesis (1 1, 13 ). An increase in ATP concentrations in the pulmonary artery of fetal lambs to levels seen in postnatal lambs resulted in pulmonary vasodilation of the magnitude seen at birth (1 1 have shown that blood and plasma ATP levels in pulmonary artery and left atrium increase during an increase in fetal Pao2. The source of increased ATP in plasma during exposure to O2 can be red cells or vascular endothelial cells. Our data indicate an increase in both whole blood and plasma levels of ATP. The difference between the two values reflects predominantly red cell ATP, because the contribution of ATP from white cells and platelets is negligible. The increase in Paoz and Hb 0 2 Sat may enhance synthesis and release of ATP by red cells into plasma. The blood ATP levels in left atrium were higher than the levels in pulmonary artery, both at baseline and during the increase in Pao2. The left atrial blood in fetus represents predominantly the umbilical venous blood, which has a higher Po2 than pulmonary arterial blood (2 1). The observation of higher blood ATP levels in the left atrium is consistent with an increase in red cell ATP levels during an increase in Pao2. However, the mechanism by which the red cell increases ATP production during increased O2 availability is not clear. The mature RBC does not have the enzymes necessary for oxidative phosphorylation and generates ATP predominantly by glycolysis (22) . Therefore, an increase in red cell ATP synthesis during an increase in Po2 does not appear likely in a mature RBC. Reticulocyte and its precursors are capable of oxidative phosphorylation (22) . Chen et al. (23) have reported that human fetal RBC contain mitochondria1 forms of isocitrate dehydrogenase, phosphoglucomutase, and other enzymes of oxidative phosphorylation. Whether these enzymes are functionally active in fetal RBC is not known and requires further study. Vascular endothelial cells may also contribute to the 538 KONDURI ET AL. increase in plasma ATP levels, because these cells are in contact otropic and inotropic effects of adenosine, and inhibition of these with plasma and contain mitochondria. The increase in fetal receptors should not limit the increase in pulmonary flow caused blood ATP levels during exposure to O2 is similar to that observed by 02. Cibacron blue has been shown to cause P2,, receptor during infusion of exogenous ATP at 0.08 to 0.15 pmol/kg/min inhibition in canine coronary arteries (28). However, the speciin fetal lambs (1 I). We reported (1 1) that infusion of ATP at ficity of this blocker for P2,, receptor in fetal pulmonary arteries these doses causes a 3-fold increase in pulmonary blood flow, has not been established previously. Our studies indicate that similar to that observed during exposure to 0 2 . Therefore, the cibacron blue, in a dose of 5 mg/kg, does not interfere with changes in blood ATP levels during O2 exposure correlate well vasodilation caused by other endothelium-dependent and -indewith the hemodynamic effects of ATP on fetal pulmonary cir-pendent vasodilators. We conclude that the inhibition of Ozculation.
induced pulmonary vasodilation in our studies was due to speThe purine nucleotides appear to exert their vasodilator effects cific inhibition of PI and P2 purinergic receptors. by stimulation of specific receptors present on endothelial and Previous studies in adult animals have shown that adenosine smooth muscle cells of blood vessels. Burnstock (24) proposed levels in coronary and cerebral circulations increase (17, 18) that the effects of purine nucleotides are mediated by two types during hypoxia. However, the response of pulmonary vessels to of purinergic receptors. PI receptors are more sensitive to aden-changes in O2 tension is opposite to that of systemic vessels. We osine, act via the adenylate cyclase system, and are inhibited by previously reported (12) that plasma adenosine levels in pulmomethylxanthines. P2 receptors are more sensitive to ATP and are nary artery and left atrium in newborn lambs decrease during not antagonized by methylxanthines. Based on receptor affinity alveolar hypoxia. We now report an increase in ATP levels in and ligand binding studies, PI receptors have been further clas-pulmonary artery during an increase in Pao2. The differences in sified into A, and A2 subtypes. A1 receptors inhibit adenylate release of nucleotides between pulmonary and systemic vessels cyclase and appear predominantly in heart, where they mediate may partly account for their different responses to O2 and the negative chronotropic and inotropic effects of adenosine (25). hypoxia. A2 receptors are present on the vascular endothelial cells, stimIn summary, our studies indicate that adenosine and ATP ulate adenylate cyclase, and mediate the vasodilator effects of have a significant role in the mediation of pulmonary vasodilaadenosine (25). P2 receptors are also classified into P2x, P2y, P2z, tion caused by O2 in fetal lambs. The plasma ATP levels in and P2t receptors (25). The relative predominance of these recep-pulmonary circulation increase during 02-induced pulmonary tors on the cell varies among different organs, P2,, receptors being vasodilation, and inhibition of receptors for adenosine and ATP more predominant in the lung. Stimulation of purine receptors causes significant attenuation of 02-induced pulmonary vasodion endothelial cells is accompanied by release of EDNO and lation. Their role as mediators of birth-associated changes in prostacyclin (ATP). Both adenosine and ATP have been shown pulmonary circulation requires further investigation in fetal to cause endothelium-dependent vasodilation in newborn (14) lambs. and fetal lambs (1 5). The pulmonary vasodilation caused by 0, in fetal lambs has been shown to be mediated predominantly by
